Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1644706
Max Phase: Preclinical
Molecular Formula: C14H12ClN3O2S
Molecular Weight: 321.79
Molecule Type: Small molecule
Associated Items:
ID: ALA1644706
Max Phase: Preclinical
Molecular Formula: C14H12ClN3O2S
Molecular Weight: 321.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(=O)n2nc(COc3ccc(Cl)c(C)c3)sc2n1
Standard InChI: InChI=1S/C14H12ClN3O2S/c1-8-5-10(3-4-11(8)15)20-7-12-17-18-13(19)6-9(2)16-14(18)21-12/h3-6H,7H2,1-2H3
Standard InChI Key: VIRCFKHDGYKTAH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 321.79 | Molecular Weight (Monoisotopic): 321.0339 | AlogP: 3.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 56.49 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.61 | CX LogD: 3.61 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.74 | Np Likeness Score: -2.41 |
1. Sathisha KR, Khanum SA, Chandra JN, Ayisha F, Balaji S, Marathe GK, Gopal S, Rangappa KS.. (2011) Synthesis and xanthine oxidase inhibitory activity of 7-methyl-2-(phenoxymethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one derivatives., 19 (1): [PMID:21163661] [10.1016/j.bmc.2010.11.034] |
Source(1):